8-K - SolarMax Technology, Inc. (0001519472) (Filer)

10-Q - SolarMax Technology, Inc. (0001519472) (Filer)

NT 10-Q - SolarMax Technology, Inc. (0001519472) (Filer)

8-K - SolarMax Technology, Inc. (0001519472) (Filer)

10-K - SolarMax Technology, Inc. (0001519472) (Filer)

8-K - SolarMax Technology, Inc. (0001519472) (Filer)

8-K - SolarMax Technology, Inc. (0001519472) (Filer)

8-K - SolarMax Technology, Inc. (0001519472) (Filer)

10-Q - SolarMax Technology, Inc. (0001519472) (Filer)

8-K - SolarMax Technology, Inc. (0001519472) (Filer)

3 - SolarMax Technology, Inc. (0001519472) (Issuer)

3 - SolarMax Technology, Inc. (0001519472) (Issuer)

3 - SolarMax Technology, Inc. (0001519472) (Issuer)

3 - SolarMax Technology, Inc. (0001519472) (Issuer)

RIVERSIDE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, today reported financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue: $6.9 million, compared with $5.8 million in the first quarter of 2024.Gross profit: $1.4 million, compared with ($0.5) million in the first quarter of 2024.   Cost of revenues in the first quarter of 2024 included a one-time, non-cash stock-based compensation expense of $1.3 million.Total operating expense: $2.6 million, compared with $18.4 million in the first quarter of 2024. Operating expense in the first quart

RIVERSIDE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, today reported financial results for the year ended December 31, 2024. 2024 Financial Highlights Revenue: $23.0 million, compared with $54.1 million in 2023.Gross profit: $2.3 million, compared with $11.1 million in 2023.   Cost of revenues in 2024 included a one-time, non-cash stock-based compensation expense of $1.3 million.Total operating expense: $35.4 million, which included a one-time, non-cash stock-based compensation expense of $17.2 million and a $7.5 million goodwill impairment relating to our China segment, compared wi

RIVERSIDE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, has entered into a Memorandum of Understanding (MOU) with Sunelement Energy Inc., a domestic manufacturer of solar panels ("Sunelement"), for the installation of a solar power and battery project in East Dublin, Georgia. The proposed project contemplates an electricity grid-connected photovoltaic solar power facility with a total capacity of approximately 40 megawatts, coupled with a battery energy storage system of 150 megawatt-hours. SolarMax is to provide the engineering, procurement, and construction ("EPC") services in connect

RIVERSIDE, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, has entered into a Memorandum of Understanding (MOU) with SOS Limited (NYSE:SOS), whose business activities include cryptocurrency mining, to develop large-scale solar power and battery storage facilities in Nevada, Texas and Florida to provide power for SOS' blockchain and cryptocurrency operations. The MOU contemplates the development of six separate facilities, each with a capacity of approximately 50 megawatts, for a combined total of approximately 300 megawatts. Under the proposed agreements, SolarMax would provide end-to-end

RIVERSIDE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, today reported financial results for the quarter ended September 30, 2024. Third Quarter Highlights Revenue: $6.3 million, compared with $14.3 million in Q3 2023.Gross profit: $1.3 million, compared with $4.0 million in Q3 2023.Total operating expense: $11.3 million, including a $7.5 million goodwill impairment relating to the China segment, compared with $3.1 million in Q3 2023.Net loss: $9.6 million, or $0.21 per share, compared with net income of $1.5 million, or $0.04 per share, in Q3 2023. David Hsu, CEO of SolarMax, stated,

ORLANDO, FL / ACCESSWIRE / August 23, 2024 / RedChip Companies will air interviews with OKYO Pharma Ltd. (NASDAQ:OKYO) and SolarMax Technology, Inc. (NASDAQ:SMXT) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, August 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:OKYO Pharma: https://www.redchip.com/assets/access/okyo_accessSolarMax: https://www.redchip.com/assets/access/smxt_accessIn an exclusive interview, Gary S. Jacob, PhD, CEO of OKYO Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate upd

RIVERSIDE, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, signed a non-binding term sheet for a significant new commercial solar project in California. The project, a major mall in the San Jose area, represents another step forward in SolarMax' ongoing strategy to expand its solar development capabilities in the US commercial market. The proposed California project is to include the development and management of a 4.17 megawatt (MW) photovoltaic solar power plant and a 2.0 MW energy storage system. As part of the project, SolarMax will also oversee the replacement of the mall's roof to su

RIVERSIDE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, today reported financial results for the quarter ended June 30, 2024. Second Quarter Highlights Revenue: $4.5 million, compared to $14.8 million in Q2 2023.Gross profit: $0.6 million, compared to $2.1 million in Q2 2023.Total operating expense: $3.0 million, compared to $3.0 million in Q2 2023.Net loss: $2.2 million ($0.05 per share), compared to a net loss of $1.9 million ($0.05 per share) in Q2 2023. David Hsu, CEO of SolarMax, stated, "Our second quarter performance reflects some of the same external factors that influenced ou

RIVERSIDE, Calif., Aug. 6, 2024 /PRNewswire/ -- SolarMax Technology, Inc. (NASDAQ:SMXT) ("SolarMax" or the "Company"), an integrated renewable energy company, is pleased to announce its plan to expand its business in the U.S. market, dedicated to leading the revolution with innovative smart solar systems. The company has signed a non-binding memorandum of understanding for its first major commercial solar installation project in the U.S. The proposed project, which is located in Las Vegas, would include a 4.27-megawatt photovoltaic solar power plant, a 2.0 megawatt energy storage system, and 10 advanced electric vehicle charging stations. This project marks a potentially significant mileston

RIVERSIDE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, announced that it plans to offer engineering, procurement and construction services, known as EPC services, for large scale solar systems in the United States, which would include both solar power and EV charging stations. As the initial step in this business plan, SolarMax has signed a non-binding memorandum of understanding for its first major commercial solar installation project in the United States. This proposed project, to be located in Las Vegas, marks a potentially significant milestone in SolarMax' strategy to offer large

ORLANDO, FL / ACCESSWIRE / August 23, 2024 / RedChip Companies will air interviews with OKYO Pharma Ltd. (NASDAQ:OKYO) and SolarMax Technology, Inc. (NASDAQ:SMXT) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, August 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:OKYO Pharma: https://www.redchip.com/assets/access/okyo_accessSolarMax: https://www.redchip.com/assets/access/smxt_accessIn an exclusive interview, Gary S. Jacob, PhD, CEO of OKYO Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate upd